| 2-Butenamide, N,N-dimethyl-4-[[2-[[5-[(1Z)-4,4,4-trifluoro-1-(3-fluoro-1H-indazol-5-yl)-2-phenyl-1-buten-1-yl]-2-pyridinyl]oxy]ethyl]amino]-, (2E)- |
H3B-6545 |
2052130-80-8 |
| H3B-5942 |
H3B-5942 |
2052128-15-9 |
| 4-chloro-2-(6-methoxypyrimidin-4-yl)aniline |
4-氯-2-(6-甲氧基嘧啶-4-基)苯胺 |
1802434-18-9 |
| Autotaxin modulator 1 |
1548743-69-6 |
1548743-69-6 |
| BIO-32546 |
BIO-32546 |
1548743-66-3 |
| 6-(2,6-dichloro-3,5-dimethoxyphenyl)-N-(2-methyl-6-nitrophenyl)quinazolin-2-amine |
CPDB3610中间体 |
1538605-09-2 |
| Tazemetostat hydrobromide (JAN/USAN) |
TAZEMETOSTAT HYDROBROMIDE |
1467052-75-0 |
| TNU9056 |
NU 9056 |
1450644-28-6 |
| RUC-4 |
CPD1217 |
1448313-27-6 |
| Naquotinib (mesylate) |
ASP-8273 |
1448237-05-5 |
| (2S,4R)-tert-butyl 4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamoyl)pyrrolidine-1-carboxylate |
1448191-54-5 |
1448191-54-5 |
| BAY-320 |
BAY-320 |
1445830-50-1 |
| 2-(3-(fluoromethyl)azetidin-1-yl)ethan-1-ol |
2-(3-(fluoromethyl)azetidin-1-yl)ethan-1-ol |
1443983-86-5 |
| 5-Bromo-4-cyclopropyl-6-methylpyrimidine |
5-BROMO-4-CYCLOPROPYL-6-METHYLPYRIMIDINE |
1434127-91-9 |
| Soticlestat |
TAK-935 |
1429505-03-2 |
| URCMKDJBULWNAI-DQEYMECFSA-N |
GSK2798745 |
1419609-94-1 |
| Vazegepant HCl |
Vazegepant HCl |
1414976-20-7 |
| Deutivacaftor |
CTP-656 |
1413431-07-8 |
| tert-butyl (1R,3R,4R)-3-hydroxy-4-methylcyclohexylcarbamate |
((1R,3R,4R)-3-羟基-4-甲基环己基)氨基甲酸叔丁酯 |
1403864-94-7 |
| CC-90001 |
CC90001 |
1403859-14-2 |
QQ
